These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Lindfors P; Unge P; Arvidsson P; Nyhlin H; Björnsson E; Abrahamsson H; Simrén M Am J Gastroenterol; 2012 Feb; 107(2):276-85. PubMed ID: 21971535 [TBL] [Abstract][Full Text] [Related]
3. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome. Smith GD J Clin Nurs; 2006 Jun; 15(6):678-84. PubMed ID: 16684163 [TBL] [Abstract][Full Text] [Related]
5. Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients with refractory irritable bowel syndrome. Dobbin A; Dobbin J; Ross SC; Graham C; Ford MJ J R Coll Physicians Edinb; 2013; 43(1):15-23. PubMed ID: 23516685 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome. Lindfors P; Unge P; Nyhlin H; Ljótsson B; Björnsson ES; Abrahamsson H; Simrén M Scand J Gastroenterol; 2012 Apr; 47(4):414-20. PubMed ID: 22339617 [TBL] [Abstract][Full Text] [Related]
7. Effects on gastrointestinal transit and antroduodenojejunal manometry after gut-directed hypnotherapy in irritable bowel syndrome (IBS). Lindfors P; Törnblom H; Sadik R; Björnsson ES; Abrahamsson H; Simrén M Scand J Gastroenterol; 2012 Dec; 47(12):1480-7. PubMed ID: 23094932 [TBL] [Abstract][Full Text] [Related]
8. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. Roberts L; Wilson S; Singh S; Roalfe A; Greenfield S Br J Gen Pract; 2006 Feb; 56(523):115-21. PubMed ID: 16464325 [TBL] [Abstract][Full Text] [Related]
9. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial. Moser G; Trägner S; Gajowniczek EE; Mikulits A; Michalski M; Kazemi-Shirazi L; Kulnigg-Dabsch S; Führer M; Ponocny-Seliger E; Dejaco C; Miehsler W Am J Gastroenterol; 2013 Apr; 108(4):602-9. PubMed ID: 23419384 [TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800 [TBL] [Abstract][Full Text] [Related]
11. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Böhn L; Störsrud S; Törnblom H; Bengtsson U; Simrén M Am J Gastroenterol; 2013 May; 108(5):634-41. PubMed ID: 23644955 [TBL] [Abstract][Full Text] [Related]
12. Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis. Devenney J; Hasan SS; Morris J; Whorwell PJ; Vasant DH Aliment Pharmacol Ther; 2024 Jan; 59(2):269-277. PubMed ID: 37927144 [TBL] [Abstract][Full Text] [Related]
13. Group hypnotherapy for irritable bowel syndrome with long-term follow-up. Gerson CD; Gerson J; Gerson MJ Int J Clin Exp Hypn; 2013; 61(1):38-54. PubMed ID: 23153384 [TBL] [Abstract][Full Text] [Related]
14. Nurse-Administered, Gut-Directed Hypnotherapy in IBS: Efficacy and Factors Predicting a Positive Response. Lövdahl J; Ringström G; Agerforz P; Törnblom H; Simrén M Am J Clin Hypn; 2015 Jul; 58(1):100-14. PubMed ID: 26046719 [TBL] [Abstract][Full Text] [Related]
15. Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement. Whitehead WE; Palsson OS; Levy RL; Feld AD; VonKorff M; Turner M Am J Gastroenterol; 2006 May; 101(5):1057-65. PubMed ID: 16573774 [TBL] [Abstract][Full Text] [Related]
16. Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: a randomized controlled study. Ringström G; Störsrud S; Posserud I; Lundqvist S; Westman B; Simrén M Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):420-8. PubMed ID: 19923998 [TBL] [Abstract][Full Text] [Related]
17. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial. Hoekman DR; Vlieger AM; Stokkers PC; Mahhmod N; Rietdijk S; de Boer NK; de Meij TG; Frankenhuis C; D'Haens GR; Benninga MA J Crohns Colitis; 2021 Jul; 15(7):1106-1113. PubMed ID: 33245332 [TBL] [Abstract][Full Text] [Related]
18. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Vlieger AM; Menko-Frankenhuis C; Wolfkamp SC; Tromp E; Benninga MA Gastroenterology; 2007 Nov; 133(5):1430-6. PubMed ID: 17919634 [TBL] [Abstract][Full Text] [Related]
19. Hypnotherapy for irritable bowel syndrome in Saudi Arabian patients. Al Sughayir MA East Mediterr Health J; 2007; 13(2):301-8. PubMed ID: 17684852 [TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome. Lövdahl J; Törnblom H; Ringström G; Palsson OS; Simrén M Aliment Pharmacol Ther; 2022 Jun; 55(12):1501-1511. PubMed ID: 35505463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]